REG - Hikma Pharmaceutical - Block listing Interim Review

Hikma PharmaceuticalsAnnouncement

03/04/2023 09:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230403:nRSC1243Va&default-theme=true

RNS Number : 1243V  Hikma Pharmaceuticals Plc  03 April 2023

Hikma Pharmaceuticals PLC

 

 

Block Listing Six Monthly Return

 

Date: 3 April 2023

 

 Name of applicant:                                                            Hikma Pharmaceuticals PLC
 Name of scheme:                                                               Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP")

 Period of return                                                              From: 1 October 2022  To:                  31 March 2023
 Balance of unallotted securities under scheme(s) from previous return:        SOP: 792,700 Ordinary Shares of 10 pence
 Plus:  The amount by which the block scheme(s) has been increased since the   SOP: 0 Ordinary Shares of 10 pence
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period     SOP: 0 Ordinary Shares of 10 pence
 (see LR3.5.7G):
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:    SOP: 792,700 Ordinary Shares of 10 pence
 The Hikma Pharmaceuticals plc 2004 Stock Option Plan has expired. No further
 shares may be issued under the block listing and no further block listing
 returns will be made in respect of this expired Plan; therefore, the block
 listing is hereby cancelled. In accordance with LR3.5.6R, a final block
 listing return in respect of this block listing is set out above in the
 prescribed form.

 

 Name of contact:              Hussein Arkhagha
 Telephone number of contact:  +44(0)20 7399 2760

 

 

Block Listing Six Monthly Return

 

Date: 3 April 2023

 

 Name of applicant:                                                            Hikma Pharmaceuticals PLC
 Name of scheme:                                                               Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP")
 Period of return                                                              From: 1 October 2022    To:                     31 March 2023
 Balance of unallotted securities under scheme(s) from previous return:        LTIP: 57,502 Ordinary Shares of 10 pence
 Plus:  The amount by which the block scheme(s) has been increased since the   LTIP: 0 Ordinary Shares of 10 pence
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period     LTIP: 0 Ordinary Shares of 10 pence
 (see LR3.5.7G):
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:    LTIP: 57,502 Ordinary Shares of 10 pence
 The Hikma Pharmaceuticals plc 2005 Long-Term Incentive Plan has expired. No
 further shares may be issued under the block listing and no further block
 listing returns will be made in respect of this expired Plan; therefore, the
 block listing is hereby cancelled. In accordance with LR3.5.6R, a final block
 listing return in respect of this block listing is set out above in the
 prescribed form.

 

 Name of contact:              Hussein Arkhagha
 Telephone number of contact:  +44(0)20 7399 2760

 

Block Listing Six Monthly Return

 

Date: 3 April 2023

 

 Name of applicant:                                                            Hikma Pharmaceuticals PLC
 Name of scheme:                                                               Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("2009 MIP")
 Period of return                                                              From: 1 October 2022      To:                       31 March 2023
 Balance of unallotted securities under scheme(s) from previous return:        2009 MIP: 0 Ordinary Shares of 10 pence
 Plus:  The amount by which the block scheme(s) has been increased since the   2009 MIP: 0 Ordinary Shares of 10 pence
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period     2009 MIP: 0 Ordinary Shares of 10 pence
 (see LR3.5.7G):
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:    2009 MIP: 0 Ordinary Shares of 10 pence
 The Hikma Pharmaceuticals plc 2009 Management Incentive Plan has expired. No
 further shares may be issued under the block listing and no further block
 listing returns will be made in respect of this expired Plan; therefore, the
 block listing is hereby cancelled. In accordance with LR3.5.6R, a final block
 listing return in respect of this block listing is set out above in the
 prescribed form.

 

 Name of contact:              Hussein Arkhagha
 Telephone number of contact:  +44(0)20 7399 2760

 

 

Block Listing Six Monthly Return

 

Date: 3 April 2023

 

 Name of applicant:                                                            Hikma Pharmaceuticals PLC
 Name of scheme:                                                               Hikma Pharmaceuticals PLC 2018 Management Incentive Plan ("2018 MIP") and
                                                                               Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP") (together "the
                                                                               Plans")
 Period of return                                                              From: 1 October 2022         To:                          31 March 2023
 Balance of unallotted securities under scheme(s) from previous return:        2018 MIP: 414,112 Ordinary Shares of 10 pence

                                                                               EIP: 354,962 Ordinary Shares of 10 pence
 Plus:  The amount by which the block scheme(s) has been increased since the   The Plans: 1,200,000 Ordinary Shares of 10 pence
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period     2018 MIP: 294,737 Ordinary Shares of 10 pence
 (see LR3.5.7G):

                                                                               EIP: 176,424 Ordinary Shares of 10 pence
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:    The Plans: 1,497,913 Ordinary Shares of 10 pence

 

 Name of contact:              Hussein Arkhagha
 Telephone number of contact:  +44(0)20 7399 2760

 

LEI: 549300BNS685UXH4JI75

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BLRUPUAPCUPWURW